| Product Code: ETC13312315 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Drug Repurposing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Drug Repurposing Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Drug Repurposing Market - Industry Life Cycle |
3.4 Africa Drug Repurposing Market - Porter's Five Forces |
3.5 Africa Drug Repurposing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.7 Africa Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Africa Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Africa Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Africa Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Drug Repurposing Market Trends |
6 Africa Drug Repurposing Market, 2021 - 2031 |
6.1 Africa Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Drug Repurposing Market, Revenues & Volume, By On-Target Repurposing, 2021 - 2031 |
6.1.3 Africa Drug Repurposing Market, Revenues & Volume, By Off-Target Repurposing, 2021 - 2031 |
6.1.4 Africa Drug Repurposing Market, Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031 |
6.1.5 Africa Drug Repurposing Market, Revenues & Volume, By Pathway-Based Repurposing, 2020 - 2028 |
6.2 Africa Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Drug Repurposing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Africa Drug Repurposing Market, Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031 |
6.2.4 Africa Drug Repurposing Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.5 Africa Drug Repurposing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3 Africa Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Drug Repurposing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.3.3 Africa Drug Repurposing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.3.4 Africa Drug Repurposing Market, Revenues & Volume, By Academic Research Institutes, 2021 - 2031 |
6.3.5 Africa Drug Repurposing Market, Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031 |
6.4 Africa Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Drug Repurposing Market, Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031 |
6.4.3 Africa Drug Repurposing Market, Revenues & Volume, By High-Throughput Screening, 2021 - 2031 |
6.4.4 Africa Drug Repurposing Market, Revenues & Volume, By Biomarker-Based Repurposing, 2020 - 2028 |
6.4.5 Africa Drug Repurposing Market, Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2020 - 2028 |
7 Africa Drug Repurposing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.1 South Africa Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.2 Egypt Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.3 Nigeria Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.4 Rest of Africa Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.3 Africa Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
7.3.1 South Africa Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.2 Egypt Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.3 Nigeria Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.4 Rest of Africa Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.4 Africa Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 South Africa Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Egypt Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Nigeria Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Rest of Africa Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Africa Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 South Africa Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Egypt Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Nigeria Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.4 Rest of Africa Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Africa Drug Repurposing Market Key Performance Indicators |
9 Africa Drug Repurposing Market - Export/Import By Countries Assessment |
10 Africa Drug Repurposing Market - Opportunity Assessment |
10.1 Africa Drug Repurposing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
10.3 Africa Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
10.4 Africa Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Africa Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Africa Drug Repurposing Market - Competitive Landscape |
11.1 Africa Drug Repurposing Market Revenue Share, By Companies, 2022 |
11.2 Africa Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here